Thursday, June 25, 2020, 9 am/PT, 12 pm/ET
Expiration date (for CME): Thursday, June 25, 2020
Length: 60 minutes
Cost: No Charge/Open to All/Please share the link with your colleagues!
On Demand Available at: SurgeryU – Click here for past webinar recordings
Join the COVID-19 Discussion Forum: http://discussion.aagl.org
Description: A central strategy for health care surge control is “forward triage” — the sorting of patients before they arrive in the emergency department (ED). Direct-to-consumer (or on-demand) telemedicine, a 21st-century approach to forward triage that allows patients to be efficiently screened, is both patient-centered and conducive to self-quarantine, and it protects patients, clinicians, and the community from exposure. It can allow physicians and patients to communicate 24/7, using smartphones or webcam-enabled computers. Respiratory symptoms — which may be early signs of COVID-19 — are among the conditions most commonly evaluated with this approach. Health care providers can easily obtain detailed travel and exposure histories. Automated screening algorithms can be built into the intake process, and local epidemiologic information can be used to standardize screening and practice patterns across providers.1
Learning Objectives: At the conclusion of this activity, the participant will be able to: 1) Discuss the benefits, limitations, burdens and adaption of telemedicine during COVID-19.
Target Audience: This educational activity is designed for all healthcare providers.
The AAGL is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AAGL designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was developed by AAGL and the information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this activity are those of the authors/faculty. They do not represent an endorsement by AAGL. In no event will AAGL be liable for any decision made or action taken in reliance upon the information provided through this activity.
Moderator:
- Rebecca L. Flyckt, MD, Division Chief, Reproductive Endocrinology and Infertility, Lilian Hanna Baldwin Endowed Chair in Obstetrics and Gynecology, Medical Director, UH Fertility Center, REI Fellowship Director, Beachwood, Ohio
Topics/Presenters:
- Telemedicine in a Surgical Referral Practice
Presenter: Kevin J.E. Stepp, MD, Director, Urogynecology and Pelvic Surgery, Atrium Health Women’s Care, Professor, Department of Obstetrics and Gynecology, Urology, Atrium Health, Associate Clinical Professor, Department Obstetrics and Gynecology, University of North Carolina – Chapel Hill, Charlotte, North Carolina - Telemedicine after COVID-19: The Brazilian Challenges
Presenter: Jefferson G. Fernandes, MD, MSc, PhD, MBA, Neurologist, Vice President, Brazilian Association of Telemedicine and Telehealth, Chairman of the Global Summit Telemedicine & Digital Health, Coordinator of the Telemedicine Education Program, Medical Association of São Paulo, Brazil, Coordinator and Professor, MBA in Health, Getulio Vargas Foundation, Rio de Janeiro, and MBA in Medicine Management and Innovation, IBCMED, São Paulo, Brazil - Telehealth: Technology Today and Tomorrow
Presenter: Steven F. Palter, MD, Founder and Medical Director of Gold Coast IVF, CEO of Lodestone Technology, Inc., Former Clinic Chief of Infertility at Yale University School of Medicine, Woodbury, New York
Recommended COVID-19 Resources:
- Journal of Minimally Invasive Gynecology (JMIG) Articles
- ACCME Clinician Resources
- Center for Disease Control and Prevention (CDC)
- CDC Travel Health Notices
- World Health Organization
Reference:
- Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679-1681. doi:10.1056/NEJMp2003539
